Dexcom G7 vs FreeStyle Libre 3 : Which One Should You Choose?

Key Differences

The Dexcom G7 and Libre 3 are both continuous glucose monitoring (CGM) systems, but they have distinct differences in technology and user experience. The Dexcom G7 features real-time glucose monitoring with alerts for high and low levels, while the Libre 3 provides a flash glucose monitoring system, requiring users to scan the sensor for readings. Additionally, the Dexcom G7 offers a mobile app with real-time data sharing, whereas the Libre 3 is more focused on individual use without automatic sharing capabilities.

Features Comparison

Both systems offer impressive features tailored for glucose management. The Dexcom G7 boasts a 10-day wear sensor with a 5-minute calibration time and provides real-time glucose readings every 5 minutes. It includes customizable alerts for glucose levels, a predictive alert feature, and the ability to share data with up to 10 followers. In contrast, the Libre 3 sensor lasts for 14 days and requires manual scanning for glucose readings, offering a more straightforward approach but lacking the continuous data streaming of Dexcom. Additionally, the Libre 3 has a lower profile design, making it less obtrusive for users.

Pricing and Value

Pricing for both CGMs varies by insurance coverage and location. The Dexcom G7 typically has a higher out-of-pocket cost due to its advanced features, with sensors priced around $350 for a month’s supply. In contrast, the Libre 3 is generally more budget-friendly, costing approximately $250 for two sensors to cover a month, given its longer wear time. However, users should consider the value of features; those who prioritize real-time monitoring and data sharing may find the additional cost of the Dexcom G7 worth it, while users focusing on basic monitoring may prefer the Libre 3’s affordability.

Ease of Use and Experience

In terms of user experience, both systems have their strengths. The Dexcom G7 is praised for its seamless integration with smartphones, providing easy access to glucose data and alerts. The app interface is user-friendly, and the ability to share data with caregivers enhances its usability. Conversely, the Libre 3 requires periodic scanning to access glucose data, which some users may find less convenient. However, its simple application and removal process are notable advantages, making it easier for users who prefer minimal interaction. Overall, the choice may come down to individual preferences regarding real-time monitoring versus ease of use.